Q1 Exports to Latin America up 1.5%

Israeli exports to Latin America (excluding diamonds) rose 1.5% in the first quarter of 2006 to $269m., with the year-on-year increase expected to be around 5%, the Israel Exports Institute said Sunday.

By SETH FREEDMAN
May 29, 2006 07:05

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Israeli exports to Latin America (excluding diamonds) rose 1.5% in the first quarter of 2006 to $269m., with the year-on-year increase expected to be around 5%, the Israel Exports Institute said Sunday. During 2005, a further 283 Israeli companies began trading with Latin America, a rise of 8% from 2004, bringing the current total of Israeli exporters dealing in Latin America to 3,811, including diamond exporters. Within the region, Paraguay saw the biggest increase in Israeli imports, up 166% over the same period of last year, to to $800,000. Exports to Brazil were the biggest loser, down 22% to $63m. Exports to Latin America are expected to reach $1.4b. for the year.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS